Published in Magn Reson Med on July 01, 2008
In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol (2009) 2.85
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J Am Chem Soc (2011) 1.41
Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater (2011) 1.33
Seeing stem cells at work in vivo. Stem Cell Rev (2014) 1.28
Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents. Nanomedicine (Lond) (2009) 1.15
In Vivo Cellular Imaging for Translational Medical Research. Curr Med Imaging Rev (2009) 1.12
Development of manganese-based nanoparticles as contrast probes for magnetic resonance imaging. Theranostics (2012) 1.09
Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use. Stem Cells Transl Med (2013) 1.07
In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin Biol Ther (2009) 1.06
Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles. Magn Reson Med (2009) 1.05
Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids. Chem Commun (Camb) (2009) 1.03
Multifunctional Magnetic Nanoparticles for Medical Imaging Applications. J Mater Chem (2009) 1.03
Manganese-based MRI contrast agents: past, present and future. Tetrahedron (2011) 1.02
Novel Preparation Methods of (52)Mn for ImmunoPET Imaging. Bioconjug Chem (2015) 0.97
Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano (2011) 0.97
Nanoparticles for imaging: top or flop? Radiology (2014) 0.97
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging. MRS Bull (2009) 0.95
Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma. Gene Ther (2012) 0.93
Magnetic resonance imaging of cells in experimental disease models. Prog Nucl Magn Reson Spectrosc (2009) 0.92
Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? Stem Cells (2010) 0.92
MR imaging of transplanted stem cells in myocardial infarction. Methods Mol Biol (2011) 0.92
Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds. J Control Release (2011) 0.91
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem (2014) 0.89
Comparison of superparamagnetic and ultrasmall superparamagnetic iron oxide cell labeling for tracking green fluorescent protein gene marker with negative and positive contrast magnetic resonance imaging. Mol Imaging (2009) 0.89
Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine. Dis Model Mech (2015) 0.89
Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging. Sci Rep (2013) 0.85
Concurrent dual contrast for cellular magnetic resonance imaging using gadolinium oxide and iron oxide nanoparticles. Int J Mol Imaging (2012) 0.84
Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84
Cell tracking in cardiac repair: what to image and how to image. Eur Radiol (2011) 0.84
Quantification of SPIO nanoparticles in vivo using the finite perturber method. Magn Reson Med (2010) 0.83
Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis. Mol Imaging (2010) 0.83
Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci (2012) 0.83
Nanoparticles and clinically applicable cell tracking. Br J Radiol (2015) 0.83
Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques. Imaging Med (2011) 0.81
Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy. Crit Rev Oncog (2014) 0.81
DNA-gadolinium-gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells. Biomaterials (2015) 0.80
In vivo detection of excitotoxicity by manganese-enhanced MRI: comparison with physiological stimulation. Magn Reson Med (2011) 0.80
The effects of magnetite (Fe₃O₄) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH₃) cells and in RAW 264.7 macrophages. Int J Nanomedicine (2012) 0.78
Functional nanoparticles for magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.77
Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking. Magn Reson Med (2014) 0.77
Off-resonance saturation MRI of superparamagnetic nanoprobes: theoretical models and experimental validations. J Magn Reson (2011) 0.77
Quantitative [Fe]MRI of PSMA-targeted SPIONs specifically discriminates among prostate tumor cell types based on their PSMA expression levels. Int J Nanomedicine (2016) 0.75
Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells. Ann Biomed Eng (2015) 0.75
Immobilization of biomolecules on the surface of inorganic nanoparticles for biomedical applications. Sci Technol Adv Mater (2010) 0.75
Tracking and Quantification of Magnetically Labeled Stem Cells using Magnetic Resonance Imaging. Adv Funct Mater (2016) 0.75
Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed (2004) 6.94
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol (2001) 4.54
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem (1999) 4.41
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology (2003) 3.71
Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed (2004) 2.74
Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood (2003) 2.50
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl (2007) 2.19
Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med (2005) 1.88
Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Med (2007) 1.88
Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage (2004) 1.86
Developing MR reporter genes: promises and pitfalls. NMR Biomed (2007) 1.70
Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med (1992) 1.33
Cell labeling for magnetic resonance imaging with the T1 agent manganese chloride. NMR Biomed (2006) 1.30
Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp Neurol (1993) 1.25
In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn Reson Med (2004) 1.20
A responsive MRI contrast agent to monitor functional cell status. Neuroimage (2006) 1.16
Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine (2006) 1.15
Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn Reson Med (2006) 1.08
Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent. Brain Res (1992) 1.06
Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging. Magn Reson Med (2005) 1.01
Manganese-enhanced MRI in a rat model of Parkinson's disease. J Magn Reson Imaging (2007) 0.99
Improved stem cell MR detectability in animal models by modification of the inhalation gas. Mol Imaging (2005) 0.96
Fiber tract-based atlas of human white matter anatomy. Radiology (2003) 10.18
Fiber tracking: principles and strategies - a technical review. NMR Biomed (2002) 8.52
DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed (2006) 7.65
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med (2003) 6.57
Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater (2004) 6.19
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23
Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med (2003) 4.57
Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med (2004) 4.25
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol (2010) 4.03
In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation (2003) 4.00
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology (2003) 3.71
Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med (2002) 3.67
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62
High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2004) 3.58
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage (2005) 3.11
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med (2008) 2.93
Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med (2006) 2.87
Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86
Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab (2006) 2.77
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed (2004) 2.74
Spatial normalization of diffusion tensor fields. Magn Reson Med (2003) 2.70
De novo determination of peptide structure with solid-state magic-angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2002) 2.66
White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage (2006) 2.55
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med (2007) 2.49
New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med (2008) 2.48
Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging (2007) 2.44
Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage (2011) 2.41
Analysis of noise effects on DTI-based tractography using the brute-force and multi-ROI approach. Magn Reson Med (2004) 2.35
The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc (2002) 2.28
Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med (2007) 2.22
In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology (2004) 2.22
Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl (2007) 2.19
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
DTI tractography based parcellation of white matter: application to the mid-sagittal morphology of corpus callosum. Neuroimage (2005) 2.13
Optimization of the irradiation power in chemical exchange dependent saturation transfer experiments. J Magn Reson (2005) 2.11
Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med (2007) 2.08
Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol (2013) 2.05
Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage (2009) 2.01
Cellular MR imaging. Mol Imaging (2005) 2.01
Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology (2010) 1.98
Routine clinical brain MRI sequences for use at 3.0 Tesla. J Magn Reson Imaging (2005) 1.94
Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med (2006) 1.94
Atlas-based analysis of neurodevelopment from infancy to adulthood using diffusion tensor imaging and applications for automated abnormality detection. Neuroimage (2010) 1.89
Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed (2013) 1.88
A framework for callosal fiber distribution analysis. Neuroimage (2002) 1.87
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging. Neuroimage (2003) 1.80
In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.78
Hot spot MRI emerges from the background. Nat Biotechnol (2005) 1.78
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Developing MR reporter genes: promises and pitfalls. NMR Biomed (2007) 1.70
Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed (2008) 1.70
Defining functional SMA and pre-SMA subregions in human MFC using resting state fMRI: functional connectivity-based parcellation method. Neuroimage (2009) 1.69
Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med (2003) 1.68
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed (2010) 1.60
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Experimental measurement of extravascular parenchymal BOLD effects and tissue oxygen extraction fractions using multi-echo VASO fMRI at 1.5 and 3.0 T. Magn Reson Med (2005) 1.56
Imaging of pancreatic islet cells. Diabetes Metab Res Rev (2011) 1.56
In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med (2008) 1.56
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation (2003) 1.55
Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp Neurol (2013) 1.54
Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem Int Ed Engl (2006) 1.54
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol (2002) 1.53
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52